Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mererid Evans

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Oncology Reports|September 18, 2020
Sensitivity of human papillomavirus‑positive and ‑negative oropharyngeal cancer cell lines to ionizing irradiationStefan Holzhauser, Evelyne Pirotte, Joanne Jones, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|June 2, 2019
Machine-learned target volume delineation of <sup>18</sup>F-FDG PET images after one cycle of induction chemotherapyCraig Parkinson, Mererid Evans, Teresa Guerrero-Urbano, et al.
Plos One|December 14, 2018
Sensitivity to inhibition of DNA repair by Olaparib in novel oropharyngeal cancer cell lines infected with Human PapillomavirusEvelyne F Pirotte, Stefan Holzhauser, David Owens, et al.
BMC Cancer|August 28, 2015
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancerWaheeda Owadally, Chris Hurt, Hayley Timmins, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 10, 2024
Transoral Laser or Robotic Surgery Outcomes for Oropharyngeal Carcinoma: Secondary Analysis of the PATHOS Randomized Clinical TrialJames T O'Hara, Christopher N Hurt, Kate Ingarfield, et al.
The Lancet. Oncology|January 25, 2021
The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based studyKatie Spencer, Christopher M Jones, Rebecca Girdler, et al.
Trials|July 24, 2025
RAPTOR: Randomised Controlled Trial of PENTOCLO (pentoxifylline-tocopherol-clodronate) in Mandibular Osteoradionecrosis-study protocol for an open-label phase II randomised controlled superiority trialRichard Shaw, Ruth Knight, Ayten Basoglu, et al.
BMJ Open|June 28, 2017
Talking about human papillomavirus and cancer: development of consultation guides through lay and professional stakeholder coproduction using qualitative, quantitative and secondary dataMaggie Hendry, Diana Pasterfield, Simon Gollins, et al.
BMJ Open|April 27, 2016
Talking about human papillomavirus and cancer: protocol for a patient-centred study to develop scripted consultationsMaggie Hendry, Di Pasterfield, Richard Adams, et al.
British Journal of Cancer|November 27, 2025
Correlation between imaging-detected and pathological extranodal extension in a randomised trial in Human Papillomavirus-positive oropharyngeal cancerMererid Evans, Chris Hurt, Rhian Rhys, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Oncology Reports|September 18, 2020
Sensitivity of human papillomavirus‑positive and ‑negative oropharyngeal cancer cell lines to ionizing irradiationStefan Holzhauser, Evelyne Pirotte, Joanne Jones, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|June 2, 2019
Machine-learned target volume delineation of <sup>18</sup>F-FDG PET images after one cycle of induction chemotherapyCraig Parkinson, Mererid Evans, Teresa Guerrero-Urbano, et al.
Plos One|December 14, 2018
Sensitivity to inhibition of DNA repair by Olaparib in novel oropharyngeal cancer cell lines infected with Human PapillomavirusEvelyne F Pirotte, Stefan Holzhauser, David Owens, et al.
BMC Cancer|August 28, 2015
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancerWaheeda Owadally, Chris Hurt, Hayley Timmins, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 10, 2024
Transoral Laser or Robotic Surgery Outcomes for Oropharyngeal Carcinoma: Secondary Analysis of the PATHOS Randomized Clinical TrialJames T O'Hara, Christopher N Hurt, Kate Ingarfield, et al.
The Lancet. Oncology|January 25, 2021
The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based studyKatie Spencer, Christopher M Jones, Rebecca Girdler, et al.
Trials|July 24, 2025
RAPTOR: Randomised Controlled Trial of PENTOCLO (pentoxifylline-tocopherol-clodronate) in Mandibular Osteoradionecrosis-study protocol for an open-label phase II randomised controlled superiority trialRichard Shaw, Ruth Knight, Ayten Basoglu, et al.
BMJ Open|June 28, 2017
Talking about human papillomavirus and cancer: development of consultation guides through lay and professional stakeholder coproduction using qualitative, quantitative and secondary dataMaggie Hendry, Diana Pasterfield, Simon Gollins, et al.
BMJ Open|April 27, 2016
Talking about human papillomavirus and cancer: protocol for a patient-centred study to develop scripted consultationsMaggie Hendry, Di Pasterfield, Richard Adams, et al.
British Journal of Cancer|November 27, 2025
Correlation between imaging-detected and pathological extranodal extension in a randomised trial in Human Papillomavirus-positive oropharyngeal cancerMererid Evans, Chris Hurt, Rhian Rhys, et al.
Pageof 5